Rodent cell transformation and immediate early gene expression following 60-hz magnetic field exposure

Environmental Health Perspectives

Volumn 104, Issue 11, 1996, Pages 1188-1198

  Balcer Kubiczek, Elizabeth K ^a,b,c,f   Zhang, Xiao Feng ^a   Harrison, George H ^a,b   McCready, Weltona ^a   Shi, Zhong Ming ^a   Man, Lin Huang ^a   Abraham, John M ^c,d   Ampey III, Luther L ^a   Meltzer, Stephen J ^b,c,d   Jacobs, Maria C ^a,b   Davis, Christopher C ^e  

^a Department of Radiation Oncology ^*  (United States)

^b Program in Oncology   (United States)

^c Molecular and Cell Biology Graduate Program   (United States)

^d UNIVERSITY OF MARYLAND SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF MARYLAND   (United States)

^f Division of Radiation Research   (United States)

Author keywords

60 Hz magnetic field; c fos; c myc; Heat; Neoplastic transformation; ODC; Ribosomal genes; SHE cells; TPA; X rays; actin

Indexed keywords

ORNITHINE DECARBOXYLASE;

ANIMAL CELL; ARTICLE; CANCER RISK; CELL STRAIN HL 60; CELL TRANSFORMATION; CONTROLLED STUDY; DATA BASE; EMBRYO; FIBROBLAST; GENE EXPRESSION; HAMSTER; HUMAN; HUMAN CELL; IMMEDIATE EARLY GENE; MAGNETIC FIELD; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; ONCOGENE C FOS; ONCOGENE C MYC; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALIA; CRICETINAE; MESOCRICETUS AURATUS; MURINAE; RODENTIA;

EID: 12644317809     PISSN: 00916765     EISSN: None     Source Type: Journal    
DOI: 10.1289/ehp.961041188     Document Type: Article

References (79)

1. Bates MN. Extremely low frequency electromagnetic fields and cancer: the epidemiologic evidence. Environ Health Perspect 95:147-156 (1991).
2. Sagan L. Epidemiological and laboratory studies of power frequency electric and magnetic fields. JAMA 268:625-629 (1992).
3. McLean JRN, Stuchly MA, Mitchel REJ, Wilkinson D, Yang H, Goddard M, Lecuyer DW, Schunk MM, Callary E, Morrison D. Cancer promotion in a mouse-skin model by a 60-Hz magnetic field: II. Tumor development and immune response. Bioelectromagnetics 12: 273-287 (1991).
4. Stuchly MA, McLean JRN, Burnett R, Goddard M, Lecuyer DW, Mitchel REJ. Modification of tumor promotion in the mouse skin by exposure to an alternating magnetic field. Cancer Lett 65:1-7 (1992).
5. Rannung A, Ekström T, Hansson Mild K, Holmberg B, Gimenez-Conti I, Slaga TJ. A study on skin tumor formation in mice with 50 Hz magnetic field exposure. Carcinogenesis 14: 573-578 (1993).
6. Rannung A, Holmberg B, Ekström T, Hansson Mild KH, Gimenez-Conti I, Slaga TJ. Intermittent 50 Hz magnetic field and skin tumor promotion in SENCAR mice. Carcinogenesis 15:153-157 (1994).
7. Svendenstål B-M, Holmberg B. Lymphoma development among mice exposed to X-rays and pulsed magnetic fields. Int J Radiat Biol 64: 119-125 (1993).
8. Cain CD, Thomas DL, Adey WR. 60 Hz magnetic field acts as co-promoter in focus formation of C3H/10T1/2 cells. Carcinogenesis 14: 955-960 (1993).
9. Rannug A, Holmberg B, Ekström T, Mild KH. A rat liver foci study on coexposure with 50 Hz magnetic field and known carcinogens. Bioelectromagnetics 14:17-27 (1993).
10. Cridland NA, Cragg TA, Haylock RGE, Sauders RD. Effects of 50 Hz magnetic field exposure on the rate of DNA synthesis. Int J Radiat Biol 69:503-511 (1996).
11. Goodman EM, Greenebaum B, Marron MT. Effects of electromagnetic fields on molecules and cells. Int Rev Cytol 158:279-330 (1995).
12. Lacy-Hulbert A, Wilkins RC, Hesketh TR, Metcalfe JC. No effect of 60 Hz electromagnetic fields on MYC or β-actin expression in human leukemic cells. Radiat Res 144:9-17 (1995).
13. Saffer JD, Thurston SJ. Short exposures to 60 Hz magnetic fields do not alter MYC expression in HL60 or Daudi cells. Radiat Res 144:18-25 (1995).
14. Desjobert H, Hillion J, Adolphe M, Averland A, Nafzinger J. Effects of 50 Hz magnetic fields on cmyc transcription levels in nonsynchronized and synchronized human cells. Bioelectromagnetics 16:277-283 (1995).
15. Heidelberger C, Freeman AE, Pienta RJ, Sivak A, Bertram JS, Casto BC, Dunkel VC, Francis MW, Kakunaga T, Little JB, Schechtman LM. Cell transformation by chemical agents - a review and analysis of the literature. Mutat Res 114:283-385 (1983).
16. Borek C, Hall EJ. Induction and modulation of radiogenic transformation in mammalian cells. In: Radiation Carcinogenesis: epidemiology and biological significance, vol 26 (Boice JD Jr, Fraumeni JF Jr, eds). New York:Raven Press, 1984:291-302.
17. Yuspa SH, Hennings H, Kulesz-Martin M, Lichti U. The study of tumor promotion in a cell culture model for mouse skin - a tissue that exhibits multistage carcinogenesis in vivo. In: Cocarcinogenesis and biological effects of tumor promoters, vol 7 (Hecker E, Kunz W, Marks R, Fusening NE, Thielman HW, eds). New York:Raven Press, 1982;217-230.
18. U.S. Council on Environmental Quality, Executive Office of the President. Hazard identification: short-term in vitro cell and tissue culture tests. In: Risk analysis: a guide to principles and methods of analyzing health and environmental risks. Springfield, Va:National Technical Information Service, 1989;80-96.
19. Reznikoff CA, Bertram JS, Brankow DW, Heildelberger C. Establishment and characterization of a cloned line C3H mouse embryo cells sensitive to postconfluence inhibition of division. Cancer Res 33:3231-3238 (1973).
20. Borek C, Hall EJ. Transformation of mammalian cells in vitro by low doses of X-rays. Nature 243:450-453 (1973).
21. LeBoeuf RA, Kerckaert GA. Enhanced morphological transformation of early passage Syrian hamster cells cultured in medium with a reduced bicarbonate concentration and pH. Carcinogenesis 8:689-697 (1987).
22. LeBoeuf RA, Kerckaert GA, Aardena J, Gibson DP. Multistage neoplastic transformation of Syrian hamster embryo cells cultured at pH 6.7. Cancer Res 50:3722-3729 (1990).
23. Mondal S, Heidelberger C. Transformation of C3H/10T1/2 mouse embryo fibroblasts by ultraviolet radiation and phorbol ester. Nature 260:710-711 (1976).
24. Balcer-Kubiczek EK, Harrison GH. Effect of X-ray dose protraction and tumor promoter on transformation induction in vitro. Int J Radiat Biol 54:81-89 (1988).
25. Balcer-Kubiczek EK, Harrison GH. Induction of neoplastic transformation in C3H/10T1/2 cells by 2.45-GHz microwaves and phorbol ester. Radiat Res 117:531-537 (1989).
26. Balcet-Kubiczek EK, Harrison GH. Neoplastic transformation in C3H/10T1/2 cells following exposure to 120-Hz modulated 2.45-GHz microwaves and phorbol ester tumor promoter. Radiat Res 126:65-72 (1991).
27. Balcer-Kubiczek EK. Experimental studies of electromagnetic field-induced carcinogenesis in cultured mammalian cells. In: On the nature of electromagnetic field interactions with biological systems. (Frey AH, ed). Austin, TX:R.G. Landes Company, 1994;142-155.
28. Little JB, Nagasawa H, Kennedy AR. DNA repair and malignant transformation: effect of X irradiation, 12-O-tetradecanoyl-phorbol-13-acetate, and protease inhibitors on transformation and sister-chromatid exchanges in mouse 10T1/2 cells. Radiat Res 79:241-255 (1979).
29. Harisiadis L, Miller RC, Harisiadis S, Hall EJ. Oncogenic transformation and hyperthermia. Br J Radiol 53:479-482 (1980).
30. Clark ER, Hahn GM, Little JB. Hyperthermia modulation of X-ray-induced oncogenic transformation of C3H/10T1/2 cells. Radiat Res 88:619-622 (1981).
31. Raaphorst GP, Azzam EI, Sargent MD, Eispenner M, Borsa J. The oncogenic potential of X rays and/or hyperthermia in C3HHOT1/2 cells. Br J Radiol 54:638-639 (1981).
32. Goodman R, Wei L-X, Xu J-C, Henderson A. Exposure of human cells to low-frequency electromagnetic fields results in quantitative changes in transcripts. Biochim Biophys Acta 1009:216-230 (1989).
33. Wei L-X, Goodman R, Henderson A. Changes in levels of c-myc and historic H2B following exposure of cells to low-frequency sinusoidal electromagnetic fields: evidence for a window effect. Bioelectromagnetics 11:269-272 (1990).
34. Goodman R, Bumann J, Wei L-X, Shirley-Henderson A. Exposure of human cells to electromagnetic fields: effect of time and field strength on transcripts levels. Electro Magnetobiol 11:19-28 (1992).
35. Goodman R, Wei LX, Bumann J, Shirley-Henderson A. Exposure to electric and magnetic (EM) fields increases transcripts in HL60 cells - does adaptation to EM fields occurs? Bioelectrochem Bioenerg 29:185-192 (1992).
36. Czerska E, Casamento J, Ning J, Swicord M, al-Barazi H, Davis C, Elson E. Comparison of the effect of ELF on c-myc oncogene expression in normal and transformed human cells. Ann NY Acad Sci 649:340-342 (1992).
37. Karabakhtsian R, Broude N, Shahs N, Kochlatyi S, Goodman R, Henderson AS. Calcium is necessary in the cell response to EM fields. FEBS Lett 349:1-6 (1994).
38. Henderson AS. Does exposure to EM fields cause cancer? In: EMF RAPID electric and magnetic fields research and public information dissemination program (Barnes M, Galvin M, Phelps J, eds). Research Triangle Park, NC:National Institute of Environmental Health Sciences, November 1995.
39. Phillips JL, Haggren W, Thomas WJ, Ishida-Jones T, Adey WR. Magnetic field-induced changes in specific gene transcription. Biochem Biophys Acta 1132:140-144 (1992).
40. Greene JJ, Skowronski WJ, Mullins JM, Nardone RM. Delineation of electric and magnetic field effects of extremely low frequency electromagnetic radiation on transcription. Biochem Biophys Res Common 174:742-749 (1991).
41. Greene JJ, Pearson SL, Skowronski WJ, Nardone RM, Mullins JM, Krause D. Gene-specific modulation of RNA synthesis and degradation by extremely low frequency electromagnetic fields. Cell Mol Biol 39:251-268 (1993).
42. Byus CV, Pieper SE, Adey WR. The effect of low-energy 60-Hz environmental electromagnetic fields upon the growth-related enzyme ornithine decarboxylase. Carcinogenesis 8:1385-1389(1987).
43. Litowirz TA, Krause D, Mullins JM. Effect of coherence time of the applied magnetic field on ornithine decarboxylase activity. Biochem Biophys Res Commun 178:862-865 (1991).
44. Collins SJ, Gallo RC, Gallagher RE. Continuous growth and differentiation of human myeloid leukemia cells in suspension culture. Nature 270:347-349 (1977).
45. Rovera G, Santoli D, Dansky C. Human promyelocytic leukemia cells in culture differentiate into macrophage-like cells when treated with a phorbol diester. Proc Natl Acad Sci USA 76:2779-2783 (1979).
46. Moshier JA, Dosescu J, Skunca M, Luk GD. Transformation of NIH/3T3 cells by ornithine decarboxylase overexpression. Cancer Res 53:2618-2622 (1993).
47. Jenumein T, Muller D, Curran T, Muller R. Extended life span and tumorigenicity of nonestablished mouse connective tissue cells transformed by the fos oncogene of FBR-MuSV. Cell 41:629-637 (1985).
48. Miller AD, Curran T, Verma IM. c-fos protein can induce cellular transformation: a novel mechanism of activation of a cellular oncogene. Cell 36:51-60 (1984).
49. Adams JM, Harris AW, Pinkert CA, Corcoran LM, Alexander WS, Gory S, Palmiter RD, Brinster RL. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature 318: 533-538(1985).
50. ar-Rushdi A, Nishkura K, Erickson J, Watt R, Rovera G, Croce C. Differential expression of the translocated and untranslocated c-myc oncogene in Burkitt lymphoma. Science 22:390-393 (1983).
51. Sariban E, Mitchell T, Kufe D. Expression of the c-fms protoocogene during human monocytic differentiation. Nature 316:64-66 (1985).
52. Mitchell RL, Zokas L, Schreiber RD, Verma IM. Rapid induction of the expression of protooncogene fos during human monocytic differentiation. Cell 40:209-217 (1985).
53. Hollander MC, Fornace AJ Jr. Induction of fos RNA by DNA-damaging agents. Cancer Res 49:1687-1692 (1989).
54. Kan C-C, Kolesnick RN. Synthetic ceramide analog, D-threo-1-phenyl-2-decanoylamino-3-morpholino-1-propanol, selectively inhibits adherence during macrophage differentiation of human leukemia cells. J Biol Chem 267:9663-9667 (1992).
55. Sherman ML, Datta R, Hallahan DE, Weichselbaum RR, Kufe DW. Ionizing radiation regulates expression of the c-jun proto-oncogene. Proc Nad Acad Sci USA 87:5663-5666 (1990).
56. Verma AK, Erickson D, Dolnick BJ. Increased mouse epidermal ornithine decarboxylase activity by the tumor promoter 12-O-tetradecanoylphorbol-13-acetate involves increased the amounts of both enzyme protein and messenger RNA. Biochem J 237:297-300 (1987).
57. Rose-John S, Fürstenberger G, Krieg P, Besembelder E, Rincke G, Marks F. Differential effects of phorbol esters on c-fos and c-myc and ornithine decarboxylase gene expression in mouse skin in vivo. Carcinogenesis 9:95-100 (1988).
58. Wrighton C, Busslinger M. Direct transcriptional stimulation of the ornithine decarboxylase gene by fos in PC12 cells but not in fibroblasts. Mol Cell Biol 13:4657-4669 (1993).
59. Bello-Fernandez C, Packham G, Cleveland JL. The ornithine decarboxylase gene is transcriptional target of c-myc. Proc Natl Acad Sci USA 90:7804-7808(1993).
60. Boessen JJB, Lohman PHM, Simons JWIM. Concomitant induction of signal transduction pathways and genetic instability by the tumor promoter 12- O-tetradecanoylphorbol-13-acetate. Carcinogenesis 12:487-492 (1991).
61. Parry JM, Parry EM, Barret JC. Tumour promoters induce mitotic aneuploidy in yeast. Nature 294:263-265 (1981).
62. Önfelt A, Nilsson K, Palmgren B. Effects of TPA on mitosis of V79 Chinese hamster cells. Reduced precision of chromosome distribution and modification of entrance into and exit out of mitosis. Carcinogenesis 14:531-535 (1993).
63. Smith O. Cells, stress and EMFs. Nature Medicine 2:23-24 (1996)
64. NIEHS. Health effect research - abstracts of projects and exposure methods. In: Electric and magnetic fields research and public information dissemination program (EMF RAPID). DOE/EE-0038, Washington:Department of Energy, 1995.
65. IARC/NCI/EPA Working Group. Cellular and molecular mechanisms of cell transformation and standardization of transformation assays of established cell lines for prediction of carcinogenic chemicals: overview and recommended protocols. Cancer Res 45:2395-2399 (1985).
66. Han A, Elkind MM. Transformation of mouse C3H/10T1/2 cells by single and fractionated doses of X-rays and fission neutrons. Cancer Res 39:123-130(1979).
67. Balcer-Kubiczek EK, Harrison GH, Thompson BW. Repair time for oncogenic transformation in C3H/10T1/2 cells subjected to protracted X-irradiation. Int J Radiat Biol 51:219-226 (1987).
68. Hieber L, Ponsel G, Roos H, Fenn S, Fromke E, Kellerer AM. Absence of a dose-rate effect in the transformation of C3H 10T1/2 cells by α-paiticles. Int J Radiat Biol Relat Stud Phys Chem Med 52:859-869 (1987).
69. Balcer-Kubiczek EK, Harrison GH, Torres BA, McCready WA. Application of the constant exposure time technique to transformation experiments with fission neutrons: failure to demonstrate dose-rate dependence. Int J Radiat Biol 65:559-569 (1994).
70. Robison JE, Harrison GH, McCuloch D, McCready WA, Cheung AY. The effects of microwaves on cell survival at elevated temperature. Radiat Res 88:542-551 (1981).
71. Gibco BRL Life Technologies. TRIzol Reagent. Doc. 101294. Gaithersberg, MD:Gibco, 1994.
72. Meiner SJ, Xhou D, Weistein WM. Tissue-specific expression of c-Ha-ras in premalignant gastrointestinal mucosae. Exp Mol Pathol 51:264-274 (1989).
73. Huang Y, Meltzer SJ, Yin J, Chang EH, Srivastava S, McDaniel T, Boynton RF, Zou Z-Q. Altered messenger RNA and unique mutational profiles of p53 and Rk in human esophageal carcinoma. Cancer Res 53:1889-1894 (1993).
74. Spanakis E. Problems related to the interpretation of autoradiographic data on gene expression using common constitutive transcripts as controls. Nucl Acids Res 21:3809-3819 (1993).
75. Spanakis E, Brouty-Boyé D. Evaluation of quantitative variation in gene expression. Nucleic Acids Res 22:799-806 (1994).
76. Rosen CF, Gajic D, Drucker DJ. Ultraviolet radiation induction of ornithine decarboxylase in rat keratinocytes. Cancer Res 50:2631-2635 (1990).
77. Thompson CB, Challoner PB, Neiman PE, Groudine M. Levels of c-myc oncogene mRNA are invariant throughout the cell cycle. Nature 314:363-365 (1985).
78. Bentley DL, Groudine M. A block to elongation is largely responsible for decreased transcription of c-myc in differentiated HL60 cells. Nature 321:702-706 (1986).
79. Bentley DL, Groudine M. Novel promoter upstream of the human c-myc gene and regulation of c-myc expression in B-cell lymphomas. Mol Cell Biol 6:3481-3489 (1986).